Campylobacter Jejuni

You have had several days of diarrhea, maybe with blood in it, cramping, and a fever. You want to know whether a bacterium is behind it, because that answer changes what happens next. This test looks directly for the DNA of Campylobacter jejuni in your stool, so it can find infections that the older method, growing the organism on a culture plate, can miss.

That gap is not small. In one multicenter US study of more than 1,500 stool specimens, culture sensitivity was about 72%, meaning it failed to detect Campylobacter in roughly 30% of specimens that other methods found positive. The organism is fragile. It dies during transport, it needs a low-oxygen atmosphere to grow, and a negative culture has never meant a negative patient.

One caveat matters. Much of the best diagnostic literature groups C. jejuni with C. coli or reports Campylobacter species as a group. Those studies are still useful for this test, but they are evidence about stool Campylobacter PCR, not always C. jejuni alone.

What This Test Actually Looks For

C. jejuni (Campylobacter jejuni) is a spiral-shaped bacterium that lives in the guts of chickens and other warm-blooded animals. Chickens often carry it without getting sick. In you, it can invade the lining of the intestine and set off inflammation, which is where the cramping, fever, and bloody stool come from.

The test finds the bacterium's DNA using polymerase chain reaction, a method that copies a specific stretch of DNA over and over until there is enough to detect. Some labs run this as a standalone quantitative assay and report a cycle threshold, or Ct value, which is a rough sign of how much bacterial DNA was in the sample. More commonly it runs as one target on a multiplex gastrointestinal panel that covers C. jejuni and C. coli together and reports only positive or negative, with no Ct value shown to you.

Which stretch of DNA the lab targets matters more than you would expect. Assays use species-specific genes such as mapA, hipO, and gyrA to separate C. jejuni from close relatives. An older target called cadF can miss strains in some regions. In a Peruvian infant cohort, a newer rpsK/rpsD assay found 23% more C. jejuni or C. coli positives than cadF did.

How It Compares to Stool Culture

Culture has been the traditional reference, and it is still the only way to get a living isolate for antibiotic susceptibility testing. But as a way of answering "do I have this," it underperforms.

Source: Buss et al. 2019; Buchan et al. 2013; Platts-Mills et al. 2014.

What this means for you: a negative stool culture from a previous workup does not rule out Campylobacter, particularly if the sample sat in transit or if you had already started antibiotics. If your symptoms fit and culture came back clean, the molecular test asks a better question.

Commercial multiplex panels that include C. jejuni report positive agreement around 97% or higher, with negative agreement above 98%, when run directly from unpreserved or Cary-Blair preserved stool. Some real-time PCR assays have detected very low spiked amounts of C. jejuni in stool. That is why PCR can stay positive when culture is already negative.

Reading a Positive Result: The Amount Matters

A positive result alone does not tell you the whole story. Molecular detection cannot tell living bacteria from leftover DNA fragments, so the amount matters. A heavy load during a matching illness is much more persuasive than a weak trace after recovery.

In the GEMS study, a large case-control study of childhood diarrhea across Africa and South Asia, researchers used quantitative PCR to separate high-burden detections that were likely causing illness from low-burden detections that might be bystanders. High-burden Campylobacter detections were more likely to behave like true causes of diarrhea, especially when they fit the symptoms and inflammatory stool findings.

How firmly this holds depends on the organism and the age group. In adults, Campylobacter load tracks reasonably well with intestinal inflammation: one clinical series found fecal calprotectin rose step by step as the Ct value fell. In very young children in high-exposure settings, the picture is murkier. A large birth-cohort study analysed Campylobacter only as present or absent, because the amount of DNA detected did not track with whether a child had diarrhea or with growth shortfalls. So treat load as a useful supporting clue, not a verdict.

Ct values are also assay-specific, and most multiplex panels never report one to you. A low Ct means more bacterial DNA. A high Ct near the assay's detection limit can mean convalescent shedding after an infection that is already resolving, non-viable DNA, or low-level carriage without disease. Do not treat the Ct as a universal cutoff.

Shedding Continues After You Feel Better

This is where people get confused. In human challenge studies, shedding starts within a day or two of exposure and rises alongside symptoms. Culture studies in infected children found stool loads commonly in the millions of organisms per gram during acute illness, and sometimes much higher.

Then it tapers off slowly. In a small prospective follow-up study that included only 19 Campylobacter cases, DNA stayed detectable by molecular testing for a median of 42 days, compared with 29 days by culture, a gap that did not reach statistical significance in a sample that size. What is clear either way is that detection continues well past the point where diarrhea has stopped. So retesting after you recover to "prove" the infection cleared will often return a weak positive. That positive usually means nothing clinically. Do not retest to confirm cure.

Post-Infectious Complications

The reason C. jejuni gets more attention than a typical food-poisoning organism is what can follow the acute illness. The most serious is Guillain-Barré syndrome, a condition where the immune system attacks peripheral nerves and causes weakness that can progress to paralysis. It happens because some surface sugars on C. jejuni can resemble sugars on human nerve cells closely enough that antibodies raised against the bacterium cross-attack the nerves.

The link is real but the complication is uncommon relative to how common the infection is, on the order of one case per 1,000 to 5,000 infections. Knowing that Campylobacter caused your illness matters if new weakness, tingling, or difficulty walking appears in the weeks after recovery, because it points a neurologist in the right direction immediately rather than after a long workup.

Appendicitis and Focal Colitis

Two tissue studies connect C. jejuni to inflammation beyond simple gastroenteritis. In a small case-control study of appendiceal tissue, appendicitis cases carried more C. jejuni DNA than control tissue, with higher tissue levels associated with substantially greater odds of appendicitis. That raises the possibility that a subset of uncomplicated appendicitis is bacterially driven, though the finding comes from a single small series and has not been tested as a treatment strategy.

Separately, among 110 colon biopsies showing focal active colitis, a pattern of scattered inflammation with the underlying architecture preserved, 19% tested positive for C. jejuni DNA. Those were biopsy PCR studies, not stool PCR studies. A stool result can support a recent infection if symptoms are still present, but it does not replace the biopsy finding.

Growth and Nutrition in Children

In children in Northeastern Brazil, C. jejuni detection in stool was associated with poorer growth measures even when there was no diarrhea. Other low-resource birth-cohort data also link repeated Campylobacter exposure with gut inflammation and growth shortfalls, though in those cohorts the association ran with whether Campylobacter was detected at all rather than with how much was present.

This can look contradictory, but it isn't. Everywhere else, a positive test without symptoms is treated as background. In young children in high-exposure settings, repeated low-grade Campylobacter exposure may contribute to chronic gut inflammation and poor growth. No diarrhea and no harm are not the same thing in a child under two. In a healthy adult, a low-level positive without symptoms is usually just background.

Why a Single Positive Is Not the Whole Answer

Serial testing is not what this marker is for. It is an acute diagnostic, not a number you track over time. What matters instead is timing: test while you are symptomatic, when the bacterial load is most likely to be high and interpretable. Testing a week after symptoms resolve tells you about shedding, not disease.

If you develop a similar illness again months later, test again. In one human rechallenge study, volunteers re-exposed to the same strain shed about a thousandfold less bacteria and had milder illness, and that protection faded over time. But protection looks strongly strain-dependent: a separate challenge study using a different C. jejuni strain found essentially no protection on rechallenge, with nearly all re-exposed volunteers getting sick again. A fresh episode deserves a fresh test, not an assumption based on the old one.

Routine repeat testing within two weeks is usually a waste. A multicenter cohort of more than 16,000 gastrointestinal panel tests found that repeating a panel within 14 days almost never produced new diagnostic information.

When Results Can Be Misleading

The most common trap is the one already covered: a weak positive late in the illness reflects residual DNA, not active infection. Beyond that, a few things distort a reading.

• Which gene the assay targets: strain-to-strain variation in a target gene can produce false negatives. If you have classic symptoms and a negative result, assay design is a legitimate reason to repeat with a broader or different method.
• Other Campylobacter species: a negative C. jejuni result does not rule out campylobacteriosis. Selective culture media and jejuni-specific assays both miss species such as C. upsaliensis and C. concisus, and in some cohorts C. concisus was detected about as often as C. jejuni. In low-resource pediatric studies, species other than jejuni and coli accounted for a large share of Campylobacter detections and were linked to severe diarrhea.
• Substances in stool that block the reaction: fecal material contains compounds that can interfere with PCR and produce a false negative. Good assays include internal controls to catch this.
• Immunocompromise: people with low antibody levels can have recurrent or prolonged Campylobacter infections. In that setting, a positive result needs to be read with symptoms and inflammatory stool markers, not taken at face value.

What to Do With an Unexpected Result

A positive with a heavy bacterial signal and matching symptoms is your answer. Bring it to a clinician, because whether to treat with antibiotics depends on severity, duration, and immune status, and because the prescription requires one. Ask whether reflex culture can still be attempted: an isolate allows antibiotic susceptibility testing, which matters given fluoroquinolone resistance now running near 28% in US isolates and considerably higher in parts of Asia.

A weak positive with no symptoms, or symptoms that already resolved, usually means residual shedding. It does not need treatment. If you are still sick despite a weak positive, the useful next step is looking elsewhere: a broader stool panel, fecal calprotectin to gauge whether the gut is actually inflamed, and consideration of non-infectious causes.

A negative result with persistent symptoms is the situation that needs the most thought. If diarrhea has run past two weeks, the workup should widen rather than repeat. That means a multiplex panel covering other bacteria, viruses, and parasites, inflammatory markers, and if it continues, a gastroenterologist and possibly endoscopy. Chronic diarrhea with a clean infectious workup is a different problem than food poisoning and gets a different investigation.

If new neurological symptoms appear after a confirmed infection, weakness starting in the legs and moving upward, tingling, or trouble walking, that is an emergency, not a wait-and-see. Go to an emergency department and say you had a confirmed Campylobacter infection.